No Data
No Data
Elken Healthcare (1789.HK): External disturbances affect performance and growth is expected to pick up in 2024
Maintain an increase in holdings rating. Considering the impact of 2023H2 external disturbances on the company's business development pace, the 2024-2025 EPS forecast was reduced to 0.23/0.33 yuan (originally 0.32/0.41 yuan)
Elken Healthcare (1789.HK): Forging ahead for 23 years, optimistic about recovery+contract renewal
Moving forward in 2023, optimistic that 2024 surgery recovery+contract renewal will boost the company's revenue of 1,094 million yuan (+4% yoy) in 2023, and net profit of 182 million yuan (-11.1% yoy) to mother
AK MEDICAL To Go Ex-Dividend On June 24th, 2024 With 0.045 HKD Dividend Per Share
March 27th - $AK MEDICAL(01789.HK)$ is trading ex-dividend on June 24th, 2024. Shareholders of record on June 25th, 2024 will receive 0.045 HKD dividend per share on July 18th, 2024. The ex-divide
Changes in Hong Kong stocks | Medical device stocks rose higher in the afternoon, and mining affected the industry's high-value consumables business growth expectations this year generally improved
Medical device stocks rose in the afternoon. As of press release, Weigao shares (01066) rose 9.25% to HK$5.08; Elken Healthcare (01,789) rose 4.35% to HK$4.08; and minimally invasive robot-B (02252) rose 1.91% to HK$13.88.
Elken Healthcare (01789) will pay a final dividend of HK$0.045 per share on July 18
Elken Healthcare (01789) announced that the company will distribute until 2024 July 18, 2023...
AK MEDICAL: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
No Data